Global Blood Therapeutics (GBT) Peer Comparison

$68.49

$0.00 (0.00%)

As on 05-Oct-2022 09:30EDT

Market cap

$4,621 Mln

Revenue (TTM)

$235 Mln

P/E Ratio

--

P/B Ratio

39

Div. Yield

0 %

Edit

	Global Blood Therapeutics (GBT)	Hanger (HNGR)	Change Healthcare (CHNG)
Market cap ($ Mln)	4,621	732	9,025
Revenue ($ Mln)	235	1,176	3,497
Net Profit ($ Mln)	-322.46	37.29	-76.95
Net Margin (%)	-151.76	3.17	-2.21
RoE (%)	-204.89	31.69	-2.35
Price to Earnings	--	19.71	--
Price-To-Book	39.05	5.85	2.74

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Global Blood Therapeutics (GBT)	Hanger (HNGR)	Change Healthcare (CHNG)
Operating Revenue	234.86	1,175.52	3,497.43
Cost of Revenue	4.45	387.78	1,641.83
Gross Profit	191.43	722.91	1,558.81
Operating Expenses	529.65	576.77	2,563.47
Operating Profit (EBIT)	-299.24	68.80	119.92
Other Income	-22.38	0.00	-14.62
Profit before Tax	-321.62	38.86	-126.43
Provision for Tax	0.84	1.57	-4.26
Profit after Tax (Net Income)	-322.46	37.29	-76.95
Minority Interest	0.00	0.00	0.00
Consolidated Profit	-322.46	37.29	-76.95

Liabilities ($ Mln)

	Global Blood Therapeutics (GBT)	Hanger (HNGR)	Change Healthcare (CHNG)
Shareholder's Funds	118.36	125.21	3,290.89
Minority Interest	0.00	0.00	0.00
Non-Current Liabilities	658.99	611.10	5,413.29
Current Liabilities	93.09	230.56	932.81
Total Liabilities	939.21	998.14	10,112.62

Assets ($ Mln)

	Global Blood Therapeutics (GBT)	Hanger (HNGR)	Change Healthcare (CHNG)
Non-Current Assets	230.43	683.96	8,490.58
Current Assets	640.01	282.91	1,146.40
Total Assets	939.21	998.14	10,112.62
Total Debt*	658.39	628.21	4,559.86
Net Current Assets	546.92	52.35	213.60

Cashflow ($ Mln)

	Global Blood Therapeutics (GBT)	Hanger (HNGR)	Change Healthcare (CHNG)
Cash From Operating Activities	-256.81	36.21	586.20
Cash Flow from Investing Activities	12.11	-102.49	-568.03
Cash from Financing Activities	434.34	-16.63	-294.34
Net Cash Inflow / Outflow	189.63	-82.91	-297.30

Ratios

Profitability Ratios

	Global Blood Therapeutics (GBT)	Hanger (HNGR)	Change Healthcare (CHNG)
ROCE (%)	-42.51	5.89	-1.37
ROE (%)	-204.89	31.69	-2.35
ROA (%)	-39.06	3.17	-0.71
EBIT Margin (%)	-126.62	5.80	4.30
Net Margin (%)	-151.76	3.17	-2.21
Cash Profit Margin (%)	0.00	0.00	0.00

Growth Ratios

	Global Blood Therapeutics (GBT)	Hanger (HNGR)	Change Healthcare (CHNG)
Revenue Growth (%)	42.53	11.71	7.15
EBIT Growth (%)	-17.25	7.00	-2.68
Net Profit Growth (%)	-21.13	25.50	-34.72
EPS Growth (%)	-16.45	24.61	-33.09
Book Value Growth (%)	-64.79	95.76	-0.41

Valuation Ratios

	Global Blood Therapeutics (GBT)	Hanger (HNGR)	Change Healthcare (CHNG)
Price / Earnings	-6.08	16.90	-63.22
Price / Book Value	9.39	6.44	2.18
Dividend Yield (%)	--	--	--
EV/EBITDA	-6.53	13.39	17.06
Market Cap ($ Cr)	--	--	--

Solvency Ratios

	Global Blood Therapeutics (GBT)	Hanger (HNGR)	Change Healthcare (CHNG)
Debt to Equity	4.92	3.66	1.36
Short term debt to equity ratio	0.05	0.40	0.01
Current Ratio	6.88	1.23	1.23
Quick Ratio	6.17	0.85	1.23
Interest Coverage	-12.02	2.33	0.45

Operating Efficiency Ratios

	Global Blood Therapeutics (GBT)	Hanger (HNGR)	Change Healthcare (CHNG)
Debtors to sales (%)	12.67	13.40	20.52
Asset Turnover	0.28	1.00	0.32
Receivable days	43.42	48.83	102.75
Inventory Days	5,420.65	75.28	--
Payable days	1,882.15	59.10	14.98
Cash Conversion Cycle	3,581.91	65.02	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly